{"denoms":[{"counts":[{"groupId":"BG000","value":"34"}],"units":"Participants"}],"groups":[{"description":"Nab-Paclitaxel, Cetuximab, Cisplatin, and Intensity-modulated radiation therapy (IMRT)","id":"BG000","title":"Single Arm: Chemotherapy With Concurrent Radiation Therapy"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","lowerLimit":"45","upperLimit":"76","value":"55.5"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"33"}],"units":"Participants"}]}],"dispersionType":"FULL_RANGE","paramType":"MEDIAN","populationDescription":"One patient receiving treatment did not complete the entire course of systemic therapy","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"12"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"21"}],"title":"Male"}],"denoms":[{"counts":[{"groupId":"BG000","value":"33"}],"units":"Participants"}]}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"One patient receiving treatment did not complete the entire course of systemic therapy","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"33"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"33"}],"units":"Participants"}],"title":"United States"}],"paramType":"NUMBER","populationDescription":"One patient receiving treatment did not complete the entire course of systemic therapy","title":"Region of Enrollment","unitOfMeasure":"participants"}],"populationDescription":"Three patients withdrew from the study prior to treatment."}